HER2 insertion YVMA mutant lung cancer: Long natural history and response to afatinib.
Li, Bob T
HER2 insertion YVMA mutant lung cancer: Long natural history and response to afatinib. [electronic resource] - Lung cancer (Amsterdam, Netherlands) Dec 2015 - 617-9 p. digital
Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural
1872-8332
10.1016/j.lungcan.2015.10.025 doi
Afatinib
Antineoplastic Agents--therapeutic use
Humans
Immunohistochemistry
Lung Neoplasms--diagnosis
Male
Middle Aged
Mutagenesis, Insertional
Protein Kinase Inhibitors--therapeutic use
Quinazolines--therapeutic use
Receptor, ErbB-2--antagonists & inhibitors
Tomography, X-Ray Computed
Treatment Outcome
HER2 insertion YVMA mutant lung cancer: Long natural history and response to afatinib. [electronic resource] - Lung cancer (Amsterdam, Netherlands) Dec 2015 - 617-9 p. digital
Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural
1872-8332
10.1016/j.lungcan.2015.10.025 doi
Afatinib
Antineoplastic Agents--therapeutic use
Humans
Immunohistochemistry
Lung Neoplasms--diagnosis
Male
Middle Aged
Mutagenesis, Insertional
Protein Kinase Inhibitors--therapeutic use
Quinazolines--therapeutic use
Receptor, ErbB-2--antagonists & inhibitors
Tomography, X-Ray Computed
Treatment Outcome